This session reviews multiple treatments for Clostridium difficile and current advancements in this terribly difficult-to-control infection, with a specific focus on the advancement of fecal microbiota transplantation.
Contact hours available until 9/14/2016.
Requirements for Successful Completion: Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Faculty, Planners, Authors, and Speakers Conflict of Interest Disclosure: Faculty, planners, authors, and speakers have no disclosures to declare.
Commercial Support and Sponsorship: No commercial support or sponsorship declared.
This educational activity has been co-provided by Anthony J. Jannetti, Inc. and Academy of Medical-Surgical Nurses.
Anthony J. Jannetti, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC-COA).
Anthony J. Jannetti, Inc. is a provider approved by the California Board of Registered nursing, Provider Number, CEP 5387.
Objectives: • Discuss Clostridium Difficile pathogenesis. • Outline standard treatments for Clostridium Difficile. • Discuss the efficacy of standard treatments. • Outline the rationale for fecal microbiota transplant (FMT). • Discuss the history and clinical studies/trials for FMT. • Describe information regarding FDA involvement. • Outline process for protocol initiation. • Discuss potential barriers to a successful program and ways to overcome.
DNP, APRN, FNP-BC,
Family Nurse Practitioner,
Blount Senior Care Partners
You must be logged in and own this session in order to